The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression
Yu-Ting Zou1, Jin-Yuan Li1, Jun-Yi Chai1
1The Second Affiliated Hospital, Nanchang University, Nanchang City, Jiangxi province, 343000, China.
Abstract:
Cancer is a significant global health concern, and finding effective methods to treat it has been a focus of scientific research. It has been discovered that the growth, invasion, and metastasis of tumors are closely related to the environment in which they exist, known as the tumor microenvironment (TME). The immune response interacting with the tumor occurring within the TME constitutes the tumor immune microenvironment, and the immune response can lead to anti-tumor and pro-tumor outcomes and has shown tremendous potential in immunotherapy. A channel called the P2X7 receptor (P2X7R) has been identified within the TME. It is an ion channel present in various immune cells and tumor cells, and its activation can lead to inflammation, immune responses, angiogenesis, immunogenic cell death, and promotion of tumor development. This article provides an overview of the structure, function, and pharmacological characteristics of P2X7R. We described the concept and components of tumor immune microenvironment and the influence immune components has on tumors. We also outlined the impact of P2X7R regulation and how it affects the development of tumors and summarized the effects of drugs targeting P2X7R on tumor progression, both past and current, assisting researchers in treating tumors using P2X7R as a target.
Insights
The P2X7 receptor (P2X7R) in the tumor microenvironment influences cancer growth and immune response. Targeting P2X7R offers potential for novel cancer immunotherapies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Cancer progression is linked to the tumor microenvironment (TME).
- The tumor immune microenvironment (TME) modulates anti-tumor and pro-tumor immune responses, crucial for immunotherapy.
- The P2X7 receptor (P2X7R), an ion channel in immune and tumor cells, plays a role in inflammation, angiogenesis, and tumor development within the TME.
Purpose of the Study:
- To provide an overview of the P2X7 receptor's structure, function, and pharmacology.
- To describe the tumor immune microenvironment and its influence on tumor progression.
- To summarize the impact of P2X7R regulation on tumor development and the efficacy of P2X7R-targeting drugs.
Main Methods:
- Literature review of P2X7R structure, function, and pharmacology.
- Analysis of the tumor immune microenvironment components and their roles.
- Review of current and past research on drugs targeting P2X7R for cancer treatment.
Main Results:
- P2X7R activation influences inflammation, immune responses, angiogenesis, and immunogenic cell death.
- Regulation of P2X7R significantly impacts tumor growth, invasion, and metastasis.
- Drugs targeting P2X7R have demonstrated effects on tumor progression, indicating therapeutic potential.
Conclusions:
- P2X7R is a key player in the tumor immune microenvironment, affecting cancer development.
- Targeting P2X7R presents a promising strategy for developing novel cancer immunotherapies.
- Further research into P2X7R modulation is essential for advancing cancer treatment.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
10:11Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
